Xingjuan Chao Sells 39,540 Shares of CeriBell (NASDAQ:CBLL) Stock

CeriBell, Inc. (NASDAQ:CBLL) CEO Xingjuan Chao sold 39,540 shares of the business’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $24.61, for a total value of $973,079.40. Following the sale, the chief executive officer owned 767,191 shares in the company, valued at $18,880,570.51. This represents a 4.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Xingjuan Chao also recently made the following trade(s):

• On Friday, August 21st, Xingjuan Chao sold 6,068 shares of CeriBell stock. The stock was sold at an average price of $24.02, for a total value of $145,753.36.
• On Wednesday, August 19th, Xingjuan Chao sold 31,415 shares of CeriBell stock. The shares were sold at an average price of $25.03, for a total value of $786,317.45.
• On Tuesday, August 18th, Xingjuan Chao sold 2,199 shares of CeriBell stock. The stock was sold at an average price of $25.00, for a total value of $54,975.00.
• On Tuesday, July 7th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The shares were sold at an average price of $19.90, for a total value of $776,100.00.
• On Monday, June 8th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The shares were sold at an average price of $18.33, for a total transaction of $714,870.00.

CeriBell Stock Up 0.6%

NASDAQ:CBLL opened at $24.72 on Friday. CeriBell, Inc. has a one year low of $10.85 and a one year high of $25.33. The company has a debt-to-equity ratio of 0.16, a current ratio of 9.18 and a quick ratio of 8.79. The company has a market cap of $948.75 million, a PE ratio of -14.05 and a beta of 0.95. The firm’s 50 day simple moving average is $20.67 and its 200 day simple moving average is $19.49.

CeriBell (NASDAQ:CBLL) last announced its quarterly earnings results on Monday, August 10th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.04). The business had revenue of $28.10 million during the quarter, compared to analyst estimates of $27.28 million. CeriBell had a negative net margin of 64.73% and a negative return on equity of 44.85%. On average, research analysts anticipate that CeriBell, Inc. will post -1.96 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have commented on CBLL shares. Barclays raised CeriBell to a “neutral” rating in a report on Tuesday, August 18th. Canaccord Genuity Group raised their price objective on CeriBell from $25.00 to $26.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Raymond James Financial reiterated a “strong-buy” rating and issued a $29.00 target price on shares of CeriBell in a report on Thursday. BTIG Research increased their target price on shares of CeriBell from $28.00 to $30.00 and gave the company a “buy” rating in a research report on Tuesday, August 18th. Finally, Weiss Ratings lowered shares of CeriBell from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, August 28th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $24.40.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Russell Investments Group Ltd. lifted its stake in shares of CeriBell by 41.4% in the 4th quarter. Russell Investments Group Ltd. now owns 2,918 shares of the company’s stock valued at $64,000 after purchasing an additional 854 shares during the period. Sei Investments Co. grew its stake in CeriBell by 2.3% during the first quarter. Sei Investments Co. now owns 50,360 shares of the company’s stock worth $923,000 after purchasing an additional 1,125 shares during the period. Caitong International Asset Management Co. Ltd increased its holdings in CeriBell by 3,971.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock worth $28,000 after purchasing an additional 1,231 shares in the last quarter. Deutsche Bank AG lifted its stake in CeriBell by 1.7% in the fourth quarter. Deutsche Bank AG now owns 85,182 shares of the company’s stock valued at $1,868,000 after buying an additional 1,393 shares during the period. Finally, Strs Ohio acquired a new position in CeriBell in the first quarter valued at approximately $27,000.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.